N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is an inhibitor of human immunodeficiency virus (HIV) replication and HIV-induced syncytium formation in vitro. Although NB-DNJ appears to inhibit HIV entry at the level of post-CD4 binding (P.B. Fischer, M. Collin, G.B. Karlsson, W. J...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Fischer, P B, Karlsson, G B, Butters, T D, Dwek, R A, Platt, F M
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190767/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8794361/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.10.7143-7152.1996
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!